Arthritis medications could reverse COVID lung damage

Arthritis drugs already available for prescription have the potential to halt lingering lung problems that can last months or years after COVID-19 infections, new research from the University of Virginia School of Medicine and Cedars-Sinai suggests.

ReCode to secure funds for cystic fibrosis gene correction

The programme utilises Intellia’s CRISPR-based gene editing platform and DNA-writing technology. Credit: Natali _ Mis/Shutterstock. ReCode Therapeutics is set to secure up to $15m in

November 19, 2024

Krill Oil Fails in New Osteoarthritis Trial

Whether an omega-3 supplement derived from tiny Antarctic shrimp-like creatures relieves knee pain from osteoarthritis (OA) no longer has a simple answer, with a new

May 23, 2024

Tweezers? Wrenches? Researchers plot prosthetics’ future with tools, not hands

Nearly half of people with upper-limb prosthetics abandon them. They’re often uncomfortable, dysfunctional or just don’t feel like a part of someone’s body. But in

June 11, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.